David Shaw’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-89,515
Closed -$7.63M 4679
2025
Q4
$7.63M Buy
+89,515
New +$7.35M ﹤0.01% 1985
2025
Q3
Sell
-171,204
Closed -$13.4M 4661
2025
Q2
$13.4M Sell
171,204
-703,202
-80% -$52.4M 0.01% 1280
2025
Q1
$63.4M Sell
874,406
-102,412
-10% -$7.33M 0.06% 406
2024
Q4
$72.3M Sell
976,818
-6,398
-0.7% -$448K 0.05% 432
2024
Q3
$64.9M Buy
983,216
+893,566
+997% +$64.9M 0.06% 413
2024
Q2
$8.28M Sell
89,650
-177,934
-66% -$15.8M 0.01% 1456
2024
Q1
$25.6M Buy
267,584
+27,795
+12% +$2.33M 0.02% 793
2023
Q4
$18.3M Sell
239,789
-183,440
-43% -$12.8M 0.02% 990
2023
Q3
$29.3M Sell
423,229
-84,632
-17% -$6.8M 0.03% 652
2023
Q2
$47.9M Sell
507,861
-2,520,545
-83% -$219M 0.05% 451
2023
Q1
$251M Buy
3,028,406
+218,112
+8% +$17.1M 0.27% 52
2022
Q4
$210M Buy
2,810,294
+2,367,796
+535% +$182M 0.23% 63
2022
Q3
$36.6M Buy
442,498
+414,199
+1,464% +$39.9M 0.04% 529
2022
Q2
$2.69M Buy
28,299
+9,906
+54% +$1.03M ﹤0.01% 2809
2022
Q1
$2.17M Sell
18,393
-34,604
-65% -$3.88M ﹤0.01% 3212
2021
Q4
$6.87M Sell
52,997
-180,423
-77% -$21M 0.01% 2045
2021
Q3
$26.4M Sell
233,420
-281,725
-55% -$32.2M 0.02% 853
2021
Q2
$53.4M Sell
515,145
-528,706
-51% -$49.8M 0.05% 508
2021
Q1
$87.3M Buy
1,043,851
+824,058
+375% +$69.7M 0.08% 275
2020
Q4
$20.1M Sell
219,793
-503,450
-70% -$41.8M 0.02% 955
2020
Q3
$57.7M Sell
723,243
-248,142
-26% -$19.4M 0.06% 371
2020
Q2
$67.1M Sell
971,385
-206,529
-18% -$14.7M 0.08% 282
2020
Q1
$74.1M Buy
1,177,914
+1,040,259
+756% +$75M 0.12% 194
2019
Q4
$10.7M Buy
137,655
+88,953
+183% +$6.95M 0.01% 1154
2019
Q3
$3.57M Sell
48,702
-164,022
-77% -$11.5M ﹤0.01% 1897
2019
Q2
$13.1M Buy
212,724
+164,148
+338% +$9.93M 0.02% 988
2019
Q1
$3.1M Sell
48,576
-16,461
-25% -$939K ﹤0.01% 1857
2018
Q4
$3.32M Sell
65,037
-409,794
-86% -$20.7M ﹤0.01% 1777
2018
Q3
$27.6M Sell
474,831
-750,501
-61% -$36.7M 0.03% 634
2018
Q2
$59.5M Sell
1,225,332
-221,205
-15% -$10.3M 0.08% 317
2018
Q1
$67.3M Buy
1,446,537
+541,530
+60% +$23.5M 0.09% 268
2017
Q4
$34M Buy
905,007
+176,835
+24% +$6.49M 0.05% 461
2017
Q3
$26.5M Buy
728,172
+562,269
+339% +$21.4M 0.04% 508
2017
Q2
$6.54M Buy
+165,903
New +$6.06M 0.01% 1154
2016
Q3
Sell
-866,250
Closed -$32.6M 3413
2016
Q2
$28.8M Buy
866,250
+827,253
+2,121% +$28.3M 0.05% 426
2016
Q1
$1.15M Buy
+38,997
New +$1.08M ﹤0.01% 2267
2015
Q3
Sell
-47,790
Closed -$1.15M 3765
2015
Q2
$1.13M Sell
47,790
-1,851,924
-97% -$41.8M ﹤0.01% 2611
2015
Q1
$45.1M Sell
1,899,714
-614,886
-24% -$13.8M 0.07% 335
2014
Q4
$53.4M Buy
2,514,600
+1,415,814
+129% +$28.4M 0.07% 335
2014
Q3
$18.7M Buy
1,098,786
+836,244
+319% +$13.2M 0.02% 737
2014
Q2
$3.76M Buy
262,542
+62,568
+31% +$848K 0.01% 1820
2014
Q1
$2.47M Sell
199,974
-178,272
-47% -$2.06M ﹤0.01% 2181
2013
Q4
$4.15M Sell
378,246
-3,646,812
-91% -$41.1M 0.01% 1855
2013
Q3
$46.7M Buy
4,025,058
+2,510,340
+166% +$29.4M 0.07% 287
2013
Q2
$17M Buy
+1,514,718
New +$17.9M 0.03% 589

Other funds holding EW

David Shaw's EW Position: Q1 2026 in Review

David Shaw sold out of Edwards Lifesciences (EW) in Q1 2026, closing a stake of 89,515 shares — an estimated $7.63M sold.

David Shaw first reported a position in EW in Q2 2013 and held it in 45 quarters. The position peaked at $251M in Q1 2023. 1,288 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • David Shaw reported no remaining Edwards Lifesciences position as of Q1 2026 after selling out during the quarter.
  • David Shaw sold 89,515 Edwards Lifesciences shares in Q1 2026, an estimated $7.63M.
  • David Shaw first reported a position in Edwards Lifesciences in Q2 2013 and held it in 45 quarters.
  • David Shaw's Edwards Lifesciences position peaked at $251M in Q1 2023.
  • 1,288 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.